David Nanchen

机构：Centre universitaire de médecine générale et santé publique, Lausanne, University of Lausanne · ORCID：0000-0002-2493-3505

发表论文 265 篇 · 总被引 4894 次 · h-index 32

代表论文

• Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort (2024 · European Journal of Preventive Cardiology · 被引 12)
• Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease (2025 · European Heart Journal · 被引 10)
• Genetic Cascade Screening for Familial Hypercholesterolemia (2026 · JAMA Network Open · 被引 1)
• Patient perspectives on a mobile health clinic for cardiovascular risk factor screening, health promotion and prevention (2026 · Patient Education and Counseling · 被引 1)
• Development and validation of an epigenetic signature of allostatic load (2025 · Bioscience Reports · 被引 1)
• Lipid clinics worldwide (2026 · DiRROS repository (University of Maribor))